Cargando…
Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734129/ https://www.ncbi.nlm.nih.gov/pubmed/33330639 http://dx.doi.org/10.3389/fcvm.2020.562708 |
_version_ | 1783622407059144704 |
---|---|
author | Diaz, Temistocles Trachtenberg, Barry H. Abraham, Samuel J. K. KosagiSharaf, Rao Durant-Archibold, Armando A. |
author_facet | Diaz, Temistocles Trachtenberg, Barry H. Abraham, Samuel J. K. KosagiSharaf, Rao Durant-Archibold, Armando A. |
author_sort | Diaz, Temistocles |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7734129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77341292020-12-15 Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 Diaz, Temistocles Trachtenberg, Barry H. Abraham, Samuel J. K. KosagiSharaf, Rao Durant-Archibold, Armando A. Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2020-11-30 /pmc/articles/PMC7734129/ /pubmed/33330639 http://dx.doi.org/10.3389/fcvm.2020.562708 Text en Copyright © 2020 Diaz, Trachtenberg, Abraham, KosagiSharaf and Durant-Archibold. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Diaz, Temistocles Trachtenberg, Barry H. Abraham, Samuel J. K. KosagiSharaf, Rao Durant-Archibold, Armando A. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title_full | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title_fullStr | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title_full_unstemmed | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title_short | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 |
title_sort | aspirin bioactivity for prevention of cardiovascular injury in covid-19 |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734129/ https://www.ncbi.nlm.nih.gov/pubmed/33330639 http://dx.doi.org/10.3389/fcvm.2020.562708 |
work_keys_str_mv | AT diaztemistocles aspirinbioactivityforpreventionofcardiovascularinjuryincovid19 AT trachtenbergbarryh aspirinbioactivityforpreventionofcardiovascularinjuryincovid19 AT abrahamsamueljk aspirinbioactivityforpreventionofcardiovascularinjuryincovid19 AT kosagisharafrao aspirinbioactivityforpreventionofcardiovascularinjuryincovid19 AT durantarchiboldarmandoa aspirinbioactivityforpreventionofcardiovascularinjuryincovid19 |